Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.

Krenzlin H, Behera P, Lorenz V, Passaro C, Zdioruk M, Nowicki MO, Grauwet K, Zhang H, Skubal M, Ito H, Zane R, Gutknecht M, Griessl MB, Ricklefs F, Ding L, Peled S, Rooj A, James CD, Cobbs CS, Cook CH, Chiocca EA, Lawler SE.

J Clin Invest. 2019 Mar 11;130:1671-1683. doi: 10.1172/JCI123375. eCollection 2019 Mar 11.

2.

Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.

Cook CH, Zhang Y, Sedmak DD, Martin LC, Jewell S, Ferguson RM.

Crit Care Med. 2006 Mar;34(3):842-9.

3.

Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations.

Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, Chiocca EA, Kwon CH.

Cancer Res. 2013 Jun 1;73(11):3441-50. doi: 10.1158/0008-5472.CAN-12-3846.

4.

A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.

Klyushnenkova EN, Kouiavskaia DV, Parkins CJ, Caposio P, Botto S, Alexander RB, Jarvis MA.

J Immunother. 2012 Jun;35(5):390-9. doi: 10.1097/CJI.0b013e3182585d50.

5.

Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes.

Caspani EM, Crossley PH, Redondo-Garcia C, Martinez S.

PLoS One. 2014 Jul 17;9(7):e101402. doi: 10.1371/journal.pone.0101402. eCollection 2014.

6.
7.

Cytomegalovirus reactivation enhances the virulence of Staphylococcus aureus pneumonia in a mouse model.

Hraiech S, Bordes J, Mège JL, de Lamballerie X, Charrel R, Bechah Y, Pastorino B, Guervilly C, Forel JM, Adda M, Rolain JM, Lepidi H, Raoult D, Lehingue S, Papazian L.

Clin Microbiol Infect. 2017 Jan;23(1):38-45. doi: 10.1016/j.cmi.2016.09.025. Epub 2016 Oct 5.

8.

VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.

Li JM, Darlak KA, Southerland L, Hossain MS, Jaye DL, Josephson CD, Rosenthal H, Waller EK.

PLoS One. 2013 May 27;8(5):e63381. doi: 10.1371/journal.pone.0063381. Print 2013.

9.

Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.

Scott GM, Ng HL, Morton CJ, Parker MW, Rawlinson WD.

J Gen Virol. 2005 Aug;86(Pt 8):2141-51.

PMID:
16033961
10.

Transfusion-transmitted cytomegalovirus (CMV) infections in a murine model: characterization of CMV-infected donor mice.

Roback JD, Su L, Newman JL, Saakadze N, Lezhava LJ, Hillyer CD.

Transfusion. 2006 Jun;46(6):889-95.

PMID:
16734804
11.

Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.

Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y.

Cancer Res. 2009 Aug 1;69(15):6057-64. doi: 10.1158/0008-5472.CAN-08-2007. Epub 2009 Jul 7.

12.

Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.

Holzki JK, Dağ F, Dekhtiarenko I, Rand U, Casalegno-Garduño R, Trittel S, May T, Riese P, Čičin-Šain L.

J Virol. 2015 Oct;89(19):9886-95. doi: 10.1128/JVI.01459-15. Epub 2015 Jul 22.

13.

Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy.

Luk K, Boatman S, Johnson KN, Dudek OA, Ristau N, Vang D, Nguyen J, Gupta K.

J Oncol. 2012;2012:458385. doi: 10.1155/2012/458385. Epub 2012 Jan 17.

15.

Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.

Jeitziner SM, Walton SM, Torti N, Oxenius A.

Eur J Immunol. 2013 Nov;43(11):2886-95. doi: 10.1002/eji.201343690. Epub 2013 Aug 26.

16.

Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.

Jordan CT, Saakadze N, Newman JL, Lezhava LJ, Maiers TT, Hillyer WM, Roback JD, Hillyer CD.

Transfusion. 2004 Aug;44(8):1159-65.

PMID:
15265119
17.

Establishment of a novel mouse model of ulcerative colitis with concomitant cytomegalovirus infection: in vivo identification of cytomegalovirus persistent infected cells.

Matsumura K, Nakase H, Kosugi I, Honzawa Y, Yoshino T, Matsuura M, Kawasaki H, Arai Y, Iwashita T, Nagasawa T, Chiba T.

Inflamm Bowel Dis. 2013 Aug;19(9):1951-63. doi: 10.1097/MIB.0b013e318293c5bf.

PMID:
23839229
18.

Nitric oxide increases the amount of murine cytomegalovirus-DNA in mice latently infected with the virus.

Okada K, Tanaka K, Noda S, Okazaki M, Koga Y.

Arch Virol. 1999;144(12):2273-90.

PMID:
10664384
19.

Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus.

Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y.

Lab Invest. 2000 Sep;80(9):1373-83.

PMID:
11005206
20.

Platelets, acting in part via P-selectin, mediate cytomegalovirus-induced microvascular dysfunction.

Khoretonenko MV, Brunson JL, Senchenkov E, Leskov IL, Marks CR, Stokes KY.

Am J Physiol Heart Circ Physiol. 2014 Dec 15;307(12):H1745-53. doi: 10.1152/ajpheart.00201.2014. Epub 2014 Oct 17.

Supplemental Content

Support Center